Stanford University
Showing 2,301-2,320 of 2,438 Results
-
Gerlinde Wernig
Associate Professor of Pathology
Current Research and Scholarly InterestsFibrotic diseases kill more people than cancer in this country and worldwide. We believe that scar-forming cells called fibroblasts are at the core of the fibrotic response in parenchymal organ fibrosis in the lung, liver, skin, bone marrow and tumor stroma. At the cellular level we think of fibrosis as a step wise process which implicates inflammation and fibrosis. We seek to identify new effective immune therapy targets to treat fibrotic diseases.
-
Marius Wernig
Professor of Pathology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsEpigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine
-
Robert West
Sabine Kohler, MD, Professor of Pathology
Current Research and Scholarly InterestsRob West, MD, PhD, is a Professor of Pathology at Stanford University Medical Center. He is a clinician scientist with experience in translational genomics research to identify new prognostic and therapeutic markers in cancer. His research focus is on the progression of neoplasia to carcinoma. His lab has developed spatially oriented in situ methods to study archival specimens. He also serves as a surgical pathologist specializing in breast pathology.
-
Lynn Marie Westphal, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsInfertility, fertility preservation, oocyte cryopreservation
-
Gordon Wetzstein
Associate Professor of Electrical Engineering and, by courtesy, of Computer Science
BioGordon Wetzstein is an Associate Professor of Electrical Engineering and, by courtesy, of Computer Science at Stanford University. He is the leader of the Stanford Computational Imaging Lab and a faculty co-director of the Stanford Center for Image Systems Engineering. At the intersection of computer graphics and vision, artificial intelligence, computational optics, and applied vision science, Prof. Wetzstein's research has a wide range of applications in next-generation imaging, wearable computing, and neural rendering systems. Prof. Wetzstein is a Fellow of Optica and the recipient of numerous awards, including an NSF CAREER Award, an Alfred P. Sloan Fellowship, an ACM SIGGRAPH Significant New Researcher Award, a Presidential Early Career Award for Scientists and Engineers (PECASE), an SPIE Early Career Achievement Award, an Electronic Imaging Scientist of the Year Award, an Alain Fournier Ph.D. Dissertation Award as well as many Best Paper and Demo Awards.
-
Cornelia Weyand
Professor of Medicine (Immunology and Rheumatology), Emerita
Current Research and Scholarly InterestsAutoimmunity
Chronic inflammatory disease
Metabolic control of immune function -
Matthew T. Wheeler
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsTranslational research in rare and undiagnosed diseases. Basic and clinical research in cardiomyopathy genetics, mechanisms, screening, and treatment. Investigating novel agents for treatment of hypertrophic cardiomyopathy and new mechanisms in heart failure. Cardiovascular screening and genetics in competitive athletes, disease gene discovery in cardiomyopathy and rare disease. Informatics approaches to rare disease and multiomics. Molecular transducers of physical activity bioinformatics.
-
Carl Wieman
Cheriton Family Professor and Professor of Physics and of Education, Emeritus
Current Research and Scholarly InterestsThe Wieman group’s research generally focuses on the nature of expertise in science and engineering, particularly physics, and how that expertise is best learned, measured, and taught. This involves a range of approaches, including individual cognitive interviews, laboratory experiments, and classroom interventions with controls for comparisons. We are also looking at how different classroom practices impact the attitudes and learning of different demographic groups.
-
Dan Wilkins
Affiliate, KIPAC
BioI am a research scientist, astronomer and astrophysicist in the Kavli Institute for Particle Astrophysics and Cosmology at Stanford University. My research focuses on how material spiralling into a supermassive black hole in the centre of a galaxy is able to release huge amounts of energy, powering some of the brightest objects we see in the Universe.
My research bridges the divide between observational and theoretical studies of black holes, using state of the art space telescopes, developing novel data analysis techniques and designing computer simulations of how light travels around black holes. I am using the X-rays that are emitted and measurements of how they reflect off of the material in its final moments before it falls in to create a 3D map of the extreme environment just outside the event horizon. I am interested in what happens to material and light just before it is lost into the black hole, how the corona that produces the radiation we see is powered, and how black holes are able to launch jets at almost the speed of light.
I am passionate about teaching and communicating science to the general public. I regularly give public lectures to a wide variety of audiences and am the founder and host of the Discover Our Universe public lecture series from Stanford's Kavli Institute of Particle Astrophysics and Cosmology. I have made a number of appearances on TV and radio, and am actively involved in a number of initiatives to involve the public in astronomy and physics. -
Francis Robert Willett
Assistant Professor of Neurosurgery
BioFrank Willett is co-director of the Neural Prosthetics Translational Laboratory. Our group develops brain-computer interfaces (BCIs) to restore movement and communication to people with neurological disorders. Recent contributions include handwriting and speech-based BCIs that set new records for communication speed and accuracy in people with paralysis. More broadly, we are interested in computational approaches to understanding brain function and recordings, with a focus on how the human brain represents movement and language.
-
Leanne Williams
Vincent V.C. Woo Professor and Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsA revolution is under way in psychiatry. We can now understand mental illness as an expression of underlying brain circuit disruptions, shaped by experience and genetics. Our lab is defining precision brain circuit biotypes for depression, anxiety and related disorders. We integrate large amounts of brain imaging, behavioral and clinical data and computational approaches. Biotypes are used in personalized intervention studies with selective drugs, neuromodulation and exploratory therapeutics.
-
Michelle Williams, ScD
Professor of Epidemiology and Population Health
BioMichelle A. Williams, ScD, is Professor of Epidemiology and Population Health and Associate Chair for Academic Affairs in the Department of Epidemiology and Population Health at Stanford University, School of Medicine.
Dr. Williams' research focuses primarily on reproductive and perinatal epidemiology. Over three decades, she has integrated epidemiological, biological, and molecular approaches into rigorously designed research that has advanced understanding of placental abruption, gestational diabetes, and preeclampsia. Her research methodology includes: (1) identifying literature gaps; (2) developing robust epidemiological data systems across North America, Sub-Saharan Africa, Asia, and South America; and (3) integrating biochemical and molecular biomarkers into these platforms. She has effectively utilized various epidemiology study designs to investigate adverse reproductive and perinatal outcomes. Her consistent goal has been using biological and molecular biomarkers as objective measures of exposures and validated pre-clinical determinants of outcomes with clinical and global health significance. In 2019, in partnership with Apple Inc. and the National Institute of Environmental Health Sciences, she co-designed and currently co-leads the Apple Women's Health Study, a large-scale digital national study examining determinants of women's gynecological health.
Dr. Williams has advanced knowledge of understudied gynecological, obstetric, and perinatal outcomes while identifying novel risk factors. Her research has been funded by multiple NIH R01s, R03s, an SBIR, and HRSA grants, and she has served as co-investigator on numerous other grants. She has published over 540 peer-reviewed scientific articles and was elected to the National Academy of Medicine in 2016. In 2020, she received the Ellis Island Medal of Honor and was recognized by PR Week as one of the top 50 health influencers of the year.
Dr. Williams has been recognized for her excellence in teaching, as the recipient of the 2015 Harvard Chan School’s Outstanding Mentor Award, the UW’s Brotman Award for excellence in teaching (2007), the American Public Health Association’s Abraham Lilienfeld Award for education in epidemiology (2007), and the White House’s Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring (2012).
Before joining Stanford, Dr. Williams served as Dean of the Faculty at the Harvard T.H. Chan School of Public Health. Prior to her deanship, she was Professor and Chair of the Department of Epidemiology at Harvard Chan School and Program Leader of Population Health and Health Disparities Research Programs at Harvard's Clinical and Translational Sciences Center.
Dr. Williams previously had a distinguished career at the University of Washington School of Public Health. She holds an undergraduate degree in biology and genetics from Princeton University, a master's in civil engineering from Tufts University, and master's and doctoral degrees in epidemiology from the Harvard Chan School. -
Nolan Williams
Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
BioNolan Williams, M.D. is a Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award and Colvin Prize). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show. -
Darrell Wilson
Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy research interests cover a number of areas in Pediatric Endocrinology and Diabetes. I am PI of the Stanford Center for the NIH-funded Type-1 Diabetes TrialNet group. TrialNet conducts clinical trials directed at preventing or delaying the onset of Type 1 diabetes. I am an investigator in DirecNet, another NIH-funded study group, which is devoted to evaluating glucose sensors and the role of technology on the management of diabetes.
-
Helen Wilson
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Wilson is a licensed clinical psychologist with expertise in the areas of trauma and life stress, women's wellness and sexual dysfunction, and lifestyle psychiatry. She provides clinical services in these areas and is Co-Director of the Lifestyle Psychiatry Clinic focused on holistic interventions incorporating physical activity, nutrition, stress management, sleep, social connection, and avoidance of risk substances. She has is also a 500 hour certified yoga instructor as has developed a group therapy program that integrates principles of yoga to support management of mood and anxiety symptoms. Dr. Wilson has completed federally funded research focused on relationships between childhood trauma and health risk behavior in adolescence and adulthood and is currently engaged in clinical research. Dr. Wilson has authored or co-authored over thirty journal articles and book chapters related to these topics, and she regularly presents her work at local and national conferences. She is lead editor of the 2023 book Facing Campus Sexual Assault and Relationship Violence With Courage: A Guide for Institutions and Clinicians on Prevention, Support, and Healing. She is currently engaged in a collaboration with Stanford Recreation and Wellness to evaluate the benefits of physical wellness and outdoor education courses.
